CMIIU
Columbus Circle Capital Corp II UnitNASDAQFINANCIAL SERVICESSHELL COMPANIES
Key Statistics
Market Cap
$422.97M
P/E Ratio
—
EPS
—
Beta
—
52W High
$0.00
52W Low
$0.00
50-Day MA
$11.53
200-Day MA
$12.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Columbus Circle Capital Corp II Unit
Columbus Circle Capital Corp II Unit (CMIIU) is a specialized acquisition company dedicated to the life sciences sector, with a focus on innovative biotechnology, pharmaceuticals, and healthcare firms that are set for growth through strategic mergers and acquisitions. Backed by a seasoned management team with extensive industry knowledge, CMIIU is well-positioned to capitalize on emerging healthcare trends and advancements in therapeutics and diagnostics. The company is committed to identifying and partnering with transformative enterprises, thereby enhancing its mission of sustainable innovation and fostering long-term value for its shareholders.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $0.14 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $27.47M |
| % Insiders | 0.00% |
| % Institutions | 64.12% |
Historical Volatility
HV 10-Day
0.00%
HV 20-Day
5.38%
HV 30-Day
5.53%
HV 60-Day
4.69%
HV Rank
—
Volatility is currently contracting
More FINANCIAL SERVICES Stocks
Data last updated: 5/25/2026